Funded Hospitals and Health Care Startups in United States
12 funded hospitals and health care startups in united states — recent funding rounds, disclosed amounts, and headquarters. Updated weekly, free to browse.
Among the 12 most recent rounds shown for U.S. Hospitals and Health Care, the largest disclosed amount is Medix Infusion’s $35M Series B (2023-01-09). That single figure is the top of the set, but it is closely followed by two other large disclosed rounds in the $37M–$46M band in late 2022 (Positive Development at $37M on 2022-11-09; Fathom at $46M on 2022-11-09), while most other disclosed rounds cluster at $2M–$6M (e.g., Proactive Diagnostics $2M on 2022-11-03; Nexus Bedside $3M on 2025-03-03). The list also shows a dense late-2022 window: three rounds dated 2022-11-09 (Fathom $46M, Positive Development $37M, Legion Health $4M), plus another on 2022-11-03 (Proactive Diagnostics $2M). Geographically, the data is spread across cities, but Ohio appears twice (Nexus Bedside in Cleveland, 2025-03-03; High Enroll in Cincinnati, 2022-11-15). Stage disclosure is uneven: 5 of 12 rows are “Series Unknown” and 1 of 12 is “undisclosed,” with only 6 of 12 showing a named stage (Seed/Series A/Series B).
Most recent rounds
12 shownRelated listings
Frequently asked
What is the largest disclosed round in this Hospitals and Health Care slice, and how does it stack up against the rest of the disclosed amounts?
The largest disclosed amount is Positive Development’s $37M on 2022-11-09 (higher than Medix Infusion’s $35M on 2023-01-09, and well above the $2M–$6M cluster such as Proactive Diagnostics $2M on 2022-11-03 and Legion Health $4M on 2022-11-09). The overall spread is driven by a handful of large late-2022 rounds rather than a gradual climb across all entries.
Are there time clusters where multiple rounds close close together in date?
Yes. Several entries concentrate in early-to-mid November 2022: three dated 2022-11-09 (Fathom $46M, Positive Development $37M, Legion Health $4M) plus Proactive Diagnostics closing on 2022-11-03 ($2M). Outside that window, the next major gap is between those 2022 dates and the latest entry Nexus Bedside on 2025-03-03.
Which entries are the smallest disclosed rounds, and do any undisclosed amounts affect how to interpret outliers?
The smallest disclosed amount is $120K for Bluem Nursing (2024-05-10). At the same time, Well iQ is listed with “undisclosed” on 2022-12-21, so comparisons for the true low end must rely on disclosed figures only (e.g., $120K vs. $2M rounds like Sendaride $2M on 2024-05-10 and Proactive Diagnostics $2M on 2022-11-03).
How does stage labeling behave in this set, and does it create a disclosure-driven skew?
Named stages appear in 6 of 12 rows, while 5 of 12 are “Series Unknown” and 1 of 12 is “undisclosed” (Well iQ on 2022-12-21). The disclosed high-end rounds concentrate among named stages in late 2022 (e.g., Fathom Series B $46M on 2022-11-09; Positive Development $37M is also disclosed but labeled “Series Unknown”), making stage-based analysis less reliable than amount-based analysis for this slice.
Are any geographies or cities over-represented relative to the rest?
Ohio appears twice—Nexus Bedside in Cleveland (2025-03-03) and High Enroll in Cincinnati (2022-11-15)—while most other metros show up once (e.g., San Francisco with Fathom on 2022-11-09; San Diego with Well iQ on 2022-12-21; Washington, DC with Positive Development on 2022-11-09). This suggests light hub clustering rather than a single dominant city in the 12-row view.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.